[ASAP] Tailored Metal-Based Catalysts: A New Platform for Targeted Anticancer Therapies

AI Summary

This article discusses the development of tailored metal-based catalysts as a new platform for targeted anticancer therapies. By designing catalysts that can selectively target cancer cells, researchers aim to improve the effectiveness of chemotherapy while minimizing side effects. Metal-based catalysts offer unique properties that can enhance drug delivery and increase therapeutic outcomes. This innovative approach has the potential to transform cancer treatment and improve patient outcomes.

Leave a Reply